Formulations used to treat ocular diseases comprising e.g. macular edema, uveitis, comprise active ingredients incorporated in nanostructured systems
Patent
Publication Date:
2016
Iris type:
06.01 Brevetto di invenzione industriale
Keywords:
Formulations; silibinin; sorafenib; curcumin; or latanoprost; solid lipid nanoparticles (SLN); nanostructured lipid carriers (NLC); micellar and nanoparticle systems; mucoadh
List of contributors: